Global Study Reveals Consistent Cancer Mortality Disadvantage for Females Aged Thirty Five to Sixty

New research in JAMA Network Open finds women aged 35-60 face higher cancer mortality than men, driven largely by reproductive cancers in 20 countries.

By: AXL Media

Published: Mar 10, 2026, 11:51 AM EDT

Source: The information in this article was sourced from JAMA Network Open

Identifying the Mid-Life Sex Gap in Cancer Survival

A sweeping international study has identified a persistent and troubling trend in global health: a significant female disadvantage in cancer mortality during middle adulthood. Researchers analyzing data from 20 low-mortality nations discovered that between the ages of 35 and 60, women consistently experience higher death rates from cancer than their male counterparts. This data, published in JAMA Network Open, challenges the general narrative of increasing life expectancy by highlighting a specific demographic window where female survival lags behind despite medical advancements.

Consistency of Mortality Disadvantage Across Birth Cohorts

The study’s findings suggest that this mortality gap is not a temporary fluctuation but a deeply ingrained pattern that has remained steady over time. By examining multiple birth cohorts, the research team, led by Vladimir Canudas-Romo, PhD, observed that the survival disparity has persisted regardless of the year a patient was born. This indicates that despite the evolution of modern healthcare, the specific risks associated with early-onset female cancers have not been mitigated at the same rate as other types of malignancies.

The Driving Force of Female Reproductive Malignancies

A central factor in this survival imbalance is the high incidence and mortality associated with reproductive cancers, including ovarian, cervical, and uterine malignancies. Unlike many male-predominant cancers that tend to manifest later in life, these female-specific diseases often strike during the highly productive years of 35 to 60. The biological and clinical complexities of these cancers create a distinct mortality profile for women that is not mirrored in the male population within the same age group.